3rd Allogeneic Cell Therapies Summit Europe

Conference Details

Date: 30 January 2024

Time: To be announced

Duration: 2 days

Location: Hilton London Olympia, London, UK

Cost: Register online for more information.

Organiser: Hanson Wade

Conference Website

Conference Description

Building Scalable Universal Cell Therapies from Bench to Bedside

After a transformative year of IND approvals and exciting clinical data, there is a novel excitement in the off-the-shelf community. Join 60+ industry experts as they discuss the current landscape and promising emerging pipelines at the 3rd Allogeneic Cell Therapies Summit Europe!

Hear expert insights from Caribou Biosciences, Adicet Bio, AdaptImmune and many more as they share their recent breakthroughs and strategies to overcome challenges such as alloreactivity, durability, and upscaling their donor-derived therapies.

As 2024 ramps up to be the turning point for regenerative medicine, there has never been a better time to connect to network with industry leaders, solve shared challenges and make your allogeneic therapy a clinical success story.

What You Will Learn:

• Whether you report to the EMA, MHRA or FDA, our Regulatory Panel will answer your burning questions about regulations for universal cell therapies.
• Take home actionable strategies to improve the longevity of your allogeneic product, inspired by the talks held by Cellectis and Smart Immune.
• Take home learnings from across cell types, with talks discussing CAR-T, Natural Killer, Gamma Delta T, Dendritic Cells and more.